Asit C Mehta is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 171 in its research report dated April 01 2024.
Asit C Mehta is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 171 in its research report dated April 01 2024. Asit C Mehta is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 171 in its research report dated April 01 2024. Moneycontrol Latest News Read More
